Status:
COMPLETED
ARB, ACEi, DRi Effects on COVID-19 Course Disease
Lead Sponsor:
Medical Practice Prof D. Ivanov
Conditions:
Hypertension
COVID-19
Eligibility:
All Genders
18-90 years
Brief Summary
It is supposed to monitor hypertensive patients who are infected or have clinical manifestations of COVID-19 for 1 month after the onset of the disease. Three groups will be considered: 1. receiving A...
Detailed Description
POEM (Patient-Oriented Evidence that Matters) intervention is performed as an open prospective randomized two medical centres trial in subjects suffering from COVID-19 who have been receiving iRAS, ei...
Eligibility Criteria
Inclusion
- Hypertensive person, stage 1-2
Exclusion
- Hypertensive subjects, stage 3, HF (NYHA) 3-4
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2021
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT04364984
Start Date
April 1 2020
End Date
August 1 2021
Last Update
March 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Practice Prof D.Ivanov
Kiev, Please Select, Ukraine, 01014